Patents by Inventor Robert G. Pendleton

Robert G. Pendleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of conditions requiring enhanced oxygen availability of mammalian tissues
    Patent number: 5015663
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: May 14, 1991
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4948582
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: May 11, 1989
    Date of Patent: August 14, 1990
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4849416
    Abstract: Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: July 18, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Robert G. Pendleton, Charles E. Pendley, II, John T. Suh, Kin T. Yu, Paul R. Menard, Tihamer Herczeg
  • .alpha..sub.2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
    Patent number: 4673680
    Abstract: Selective .alpha..sub.2 -adrenergic receptor antagonists are effective in modifying gastrointestinal motility in a manner useful in the treatment of colonic spasm, irritable bowel syndrome and constipation.
    Type: Grant
    Filed: September 18, 1985
    Date of Patent: June 16, 1987
    Inventor: Robert G. Pendleton
  • Method of producing alpha.sub.2 antagonism
    Patent number: 4352809
    Abstract: Method of producing alpha.sub.2 antagonism by administering thiadiazolo- and oxadiazolotetrahydroisoquinoline compounds.
    Type: Grant
    Filed: September 4, 1981
    Date of Patent: October 5, 1982
    Assignee: Smithkline Corporation
    Inventors: William E. Bondinell, Robert M. DeMarinis, Jacob P. Hieble, Robert G. Pendleton
  • 7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds
    Patent number: 4228170
    Abstract: 1,2,3,4-Tetrahydroisoquinoline compounds having 7- and/or 8-sulfur substituents are inhibitors of phenylethanolamine N-methyltransferase.
    Type: Grant
    Filed: August 30, 1979
    Date of Patent: October 14, 1980
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Robert G. Pendleton
  • 4- and 5-Substituted 2,3-dihydro-1H-isoindoles, pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
    Patent number: 4218464
    Abstract: Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using novel 2,3-dihydro-1H-isoindole compounds having 4- and 5-substituents.
    Type: Grant
    Filed: March 2, 1979
    Date of Patent: August 19, 1980
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Robert G. Pendleton
  • Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
    Patent number: 4208430
    Abstract: Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using substituted carbamimidothioic acid phenylalkyl esters.
    Type: Grant
    Filed: March 15, 1979
    Date of Patent: June 17, 1980
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Robert G. Pendleton
  • Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
    Patent number: 4192888
    Abstract: Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using 2-indanamine compounds having 4 and/or 5 substituents.
    Type: Grant
    Filed: April 10, 1978
    Date of Patent: March 11, 1980
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Robert G. Pendleton
  • 4 AND 5-Halo substituted 2-indanamine compounds
    Patent number: 4128666
    Abstract: 2-Indanamine compounds having 4 and 5-halo substituents are inhibitors of phenylethanolamine N-methyltransferase.
    Type: Grant
    Filed: August 18, 1977
    Date of Patent: December 5, 1978
    Assignee: SmithKline Corporation
    Inventors: William E. Bondinell, Robert G. Pendleton
  • Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
    Patent number: 4062961
    Abstract: Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using 7 and/or 8 substituted 1,2,3,4-tetrahydroisoquinoline compounds.
    Type: Grant
    Filed: August 5, 1976
    Date of Patent: December 13, 1977
    Assignee: SmithKline Corporation
    Inventors: Carl Kaiser, Robert G. Pendleton
  • Pharmaceutical compositions and method of producing anti-Parkinsonism activity
    Patent number: 4052506
    Abstract: Pharmaceutical compositions and method of producing anti-Parkinsonism activity by administering internally a nontoxic effective quantity of a benzazepine derivative to an animal.
    Type: Grant
    Filed: August 5, 1975
    Date of Patent: October 4, 1977
    Assignee: SmithKline Corporation
    Inventors: Carl Kaiser, Robert G. Pendleton, Paulette E. Setler
  • Pharmaceutical compositions and methods involving benzazepine derivatives
    Patent number: 4011319
    Abstract: Pharmaceutical compositions and a method of stimulating peripheral dopamine receptors by administering internally a nontoxic effective quantity of a benzazepine derivative to an animal. Renal vasodilator and diuretic methods are also disclosed.
    Type: Grant
    Filed: July 2, 1975
    Date of Patent: March 8, 1977
    Assignee: SmithKline Corporation
    Inventors: Carl Kaiser, Robert G. Pendleton
  • Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
    Patent number: 3988339
    Abstract: Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using 7 and/or 8 substituted 1,2,3,4-tetrahydroisoquinoline compounds.
    Type: Grant
    Filed: June 26, 1975
    Date of Patent: October 26, 1976
    Assignee: SmithKline Corporation
    Inventors: Carl Kaiser, Robert G. Pendleton
  • 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds
    Patent number: 3939164
    Abstract: 1,2,3,4-Tetrahydroisoquinoline compounds having 7 and 8 halo substituents are inhibitors of phenylethanolamine N-methyltransferase.
    Type: Grant
    Filed: February 8, 1974
    Date of Patent: February 17, 1976
    Assignee: SmithKline Corporation
    Inventors: Carl Kaiser, Robert G. Pendleton